Analysts & Vara consensus

Our coverage & latest figures

Sell-side analyst coverage

A wide range of sell-side analysts provide coverage of DSM for their clients and the broader market is contributing to the VARA consensus in 2019/20.

Institution Analyst
ABN AMRO Mutlu Gundogan
AllianceBernstein Gunther Zechman
Baader Helvea Laura Lopez Pineda
Bank of America Merrill Lynch Matthew Yates
Barclays Sebastian Satz
Berenberg Bank Sebastian Bray
Citigroup Thomas Wrigglesworth
Credit Suisse Chris Counihan
Davy Research Katy Hutchinson
Deutsche Bank Virginie Boucher-Ferte
Equita Massimo Bonisoli
Exane BNP Paribas Nicola Tang
Goldman Sachs Theodora Lee Joseph
HSBC Martin Evans
ING Reg Watson
Jefferies Laurence Alexander
JP Morgan Chetan Udeshi
KBC Securities Wim Hoste
Kepler Chevreux Martin R?diger
Mainfirst Bank Andreas Heine
Morgan Stanley Alexandra Thrum
DeGroof Petercam Fernand de Boer
Redburn Ranulf Orr
Société Générale Thomas Swoboda
The Idea Paul Hofman
UBS Andrew Stott

Disclaimer
Any opinions, forecasts, estimates, projections or predictions regarding DSM’s performance made by the analysts are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of DSM or its management. By providing the names of the analysts, DSM does not imply its endorsement of or concurrence with their reports, conclusions or recommendations. DSM assumes no liability for the accuracy of the information provided by analysts and undertakes no obligation to update this information.

Latest consensus figures

The most recent consensus figures provided by Vara Research are detailed below. The figures are based on the estimates given by the banks that were approached.

Analysts’ consensus Q1 2020 and FY 2020 as at 8 April 2020

? Q1 2019 FY 2019 Q1 2020 (est.) FY?2020 (est.)
Sales (continuing) ? ? ? ?
Number of Estimates ? ? 21 23
Highest ? ? 2,341 9,462
Consensus 2,292 9,010 2,241 8,961
Median ? ? 2,238 8,940
Lowest ? ? 2,164 8,443
adjusted EBITDA (continuing) ? ? ? ?
Number of Estimates ? ? 20 23
Highest ? ? 425 1,825
Consensus 424 1,684 412 1,675
Median ? ? 416 1,682
Lowest ? ? 373 1,520
adjusted EBIT (continuing) ? ? ? ?
Number of Estimates ? ? 21 22
Highest ? ? 276 1,209
Consensus 279 1,075 256 1,061
Median ? ? 259 1,054
Lowest ? ? 208 897
? ? ? ? ?
Nutrition, Sales ? ? ? ?
Number of Estimates ? ? 21 22
Highest ? ? 1,617 6,577
Consensus 1,517 6,028 1,543 6,292
Median ? ? 1,537 6,282
Lowest ? ? 1,480 6,004
Nutrition, adjusted EBITDA ? ? ? ?
Number of Estimates ? ? 20 21
Highest ? ? 331 1,425
Consensus 316 1,250 319 1,320
Median ? ? 321 1,337
Lowest ? ? 294 1,198
Nutrition, adjusted EBIT ? ? ? ?
Number of Estimates ? ? 20 20
Highest ? ? 238 1,050
Consensus 228 881 222 939
Median ? ? 223 959
Lowest ? ? 194 810
Materials, Sales ? ? ? ?
Number of Estimates ? ? 21 22
Highest ? ? 697 2,644
Consensus 717 2,746 638 2,435
Median ? ? 640 2,464
Lowest ? ? 592 1,906
Materials, adjusted EBITDA ? ? ? ?
Number of Estimates ? ? 20 21
Highest ? ? 121 481
Consensus 127 509 112 437
Median ? ? 112 443
Lowest ? ? 98 338
Materials, adjusted EBIT ? ? ? ?
Number of Estimates ? ? 20 20
Highest ? ? 86 351
Consensus 93 363 76 295
Median ? ? 76 300
Lowest ? ? 58 178
Innovation Center, Sales ? ? ? ?
Number of Estimates ? ? 21 22
Highest ? ? 56 235
Consensus 47 194 49 202
Median ? ? 49 202
Lowest ? ? 45 180
Innovation Center, adjusted EBITDA ? ? ? ?
Number of Estimates ? ? 20 21
Highest ? ? 9 37
Consensus 6 22 6 26
Median ? ? 6 26
Lowest ? ? 5 20
Innovation Center, adjusted EBIT ? ? ? ?
Number of Estimates ? ? 20 20
Highest ? ? -1 -5
Consensus -1 -19 -4 -16
Median ? ? -4 -16
Lowest ? ? -8 -32
Corporate Activities, Sales ? ? ? ?
Number of Estimates ? ? 21 22
Highest ? ? 18 70
Consensus 11 42 11 45
Median ? ? 11 44
Lowest ? ? 10 39
Corporate Activities, adjusted EBITDA ? ? ? ?
Number of Estimates ? ? 20 21
Highest ? ? -21 -82
Consensus -25 -97 -25 -99
Median ? ? -25 -99
Lowest ? ? -32 -118
Corporate Activities, adjusted EBIT ? ? ? ?
Number of Estimates ? ? 20 20
Highest ? ? -34 -136
Consensus -41 -150 -38 -150
Median ? ? -38 -150
Lowest ? ? -43 -162
Profit for the period, before exceptional items - Continuing Operations ? ? ? ?
Number of Estimates ? ? 19 22
Highest ? ? 208 872
Consensus 200.0 830.0 184 778
Median ? ? 186 779
Lowest ? ? 137 606
Net EPS before exceptional items - Continuing Operations ? ? ? ?
Number of Estimates ? ? 19 22
Highest ? ? 1.23 5.26
Consensus 1.12 4.64 1.06 4.53
Median ? ? 1.08 4.47
Lowest ? ? 0.77 3.44

Disclaimer
Consensus earnings estimates are based on earnings projections made by securities analysts who cover DSM. Any opinions, forecasts, estimates, projections or predictions regarding DSM’s performance made by the analysts (and, therefore, the Consensus estimate numbers) are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of DSM or its management. DSM does not by providing these estimates imply its endorsement of or concurrence with such information, conclusions or recommendations. DSM assumes no liability for the accuracy of such estimates and undertakes no obligation to update or revise such estimate

Read more

  • Results center

    Instant overview of the financial results, updates, presentations & AGMs and all DSM's financial and regulatory press releases from the last decade.

  • Share center

    DSM's ordinary shares, share performance, share listings, share structure, cumulative preference shares and shareholder base.

This site uses cookies to store information on your computer.

Learn more
超级碰碰青草免费视频